CL Colgate-Palmolive Company

$79.53

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Colgate-Palmolive's upcoming earnings report on August 1st is set against a backdrop of steady consumer demand for essential goods, positioning the company to potentially exceed expectations. With an EPS estimate of $0.90 and a revenue forecast of $5.04 billion, the market is keenly watching for signs of resilience in Colgate's core oral care and personal hygiene segments. The whisper number of $0.98 suggests that investors are optimistic about the company's ability to leverage its strong brand portfolio and global reach to deliver better-than-expected results. Despite the lack of recent news, Colgate's robust market cap of approximately $72 billion underscores its solid standing in the consumer goods sector. As the company navigates through a competitive landscape, any strategic initiatives aimed at expanding market share or enhancing operational efficiency will be pivotal in driving future growth.

Updated On 12/31/2025

About Colgate-Palmolive Company

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Website: https://www.colgatepalmolive.com

Sector
LIFE SCIENCES
Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
21665
Address
300 PARK AVE, NEW YORK, NY, US
Valuation
Market Cap
$77.46B
P/E Ratio
27.21
PEG Ratio
2.06
Price to Book
365.37
Performance
EPS
$3.51
Dividend Yield
2.18%
Profit Margin
14.40%
ROE
40.60%
Technicals
50D MA
$91.01
200D MA
$95.57
52W High
$107.54
52W Low
$84.85
Fundamentals
Shares Outstanding
811M
Target Price
$97.73
Beta
0.40

CL EPS Estimates vs Actual

Estimated
Actual

CL News & Sentiment

Dec 31, 2025 • MarketBeat NEUTRAL
VIRGINIA RETIREMENT SYSTEMS ET Al Has $106.54 Million Holdings in Colgate-Palmolive Company $CL
VIRGINIA RETIREMENT SYSTEMS ET Al significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 44.5% during the third quarter, bringing its total holdings to 1,332,700 shares valued at $106.54 million. This makes Colgate-Palmolive the 25th largest position in their investment portfolio, representing approximately 0.7%. Other institutional investors also adjusted their positions in CL, with several analysts offering a "Moderate Buy" consensus rating and an average target price of $88.81.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Smith Salley Wealth Management Boosts Stake in Colgate-Palmolive Company $CL
Smith Salley Wealth Management significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 698.5% in Q3, adding 110,034 shares to reach a total of 125,787 shares valued at approximately $10.055 million. This increase in institutional ownership comes as Colgate-Palmolive reported solid Q3 earnings, beating EPS estimates, and announced a quarterly dividend. Wall Street analysts currently hold a "Moderate Buy" consensus on the stock with an average target price of $88.81.
Dec 31, 2025 • AD HOC NEWS NEUTRAL
The Truth About Newell Brands Inc: Is This Boring Stock Secretly a Massive Comeback Play?
Newell Brands, despite its "boring" stock image, is a company behind many household names like Sharpie and Yankee Candle. The stock has seen a significant price drop, making it a potential value play for patient investors, particularly as the company focuses on core brands and dividend restoration. While not a "meme stock," its products are prevalent in lifestyle content, offering a unique avenue for a quiet comeback.
Dec 30, 2025 • Insider Monkey NEUTRAL
Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook
BofA recently raised its price target for Colgate-Palmolive (NYSE:CL) to $90 from $88, maintaining a Buy rating while expressing caution about consumption growth in the consumer staples sector for 2026. Conversely, Jefferies, while more constructive on the household and personal care space overall due to easing macro pressures, adopted a more reserved outlook for Colgate-Palmolive due to softer expectations for oral care and slowing demand in premium pet products. Colgate-Palmolive itself acknowledges a challenging operating environment marked by consumer uncertainty, tariffs, geopolitics, and high cost inflation, yet remains focused on its 2030 Strategy leveraging strong brands and emerging market exposure.
Dec 30, 2025 • openPR.com BULLISH
Hotel Toiletries Market to Boom Worldwide By 2025-2032 | Unilever PLC, Eco-Soap Bank, Colgate-Palmolive Company
This report by Coherent Market Insights forecasts significant growth in the Hotel Toiletries Market from 2025 to 2032, driven by innovation and shifting dynamics. It offers insights into market segmentation, key players, regional coverage, and strategic considerations for decision-makers. The study aims to help businesses navigate the evolving market and capitalize on upcoming opportunities.
Dec 30, 2025 • MarketBeat NEUTRAL
Colgate-Palmolive Company $CL Shares Sold by Ethic Inc.
Ethic Inc. significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 12.4% in the third quarter of 2025, selling 15,512 shares and holding 109,824 shares valued at $8.78 million. Despite mixed analyst adjustments to price targets, the consensus rating for CL remains a "Moderate Buy" with an average target of $88.81. Colgate-Palmolive also announced a quarterly dividend of $0.52 per share, payable on February 13, 2026, to shareholders of record on January 21, 2026, representing a 2.6% yield.
Sentiment Snapshot

Average Sentiment Score:

0.136
50 articles with scored sentiment

Overall Sentiment:

Neutral

CL Reported Earnings

Aug 01, 2025
Jun 30, 2025 (Pre market)
0.03 Surprise
  • Reported EPS: $0.92
  • Estimate: $0.89
  • Whisper:
  • Surprise %: 3.4%
Apr 25, 2025
Mar 31, 2025 (Pre market)
0.05 Surprise
  • Reported EPS: $0.91
  • Estimate: $0.86
  • Whisper:
  • Surprise %: 5.8%
Jan 31, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.91
  • Estimate: $0.89
  • Whisper:
  • Surprise %: 2.2%
Oct 25, 2024
Sep 30, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.91
  • Estimate: $0.88
  • Whisper:
  • Surprise %: 3.4%
Jul 26, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.91
  • Estimate: $0.87
  • Whisper:
  • Surprise %: 4.6%
Apr 26, 2024
Mar 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $0.86
  • Estimate: $0.81
  • Whisper:
  • Surprise %: 6.2%
Jan 26, 2024
Dec 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.87
  • Estimate: $0.85
  • Whisper:
  • Surprise %: 2.4%
Oct 27, 2023
Sep 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $0.86
  • Estimate: $0.80
  • Whisper:
  • Surprise %: 7.5%
Jul 28, 2023
Jun 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.77
  • Estimate: $0.75
  • Whisper:
  • Surprise %: 2.7%

Financials